Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724603 | SCV000232264 | uncertain significance | not provided | 2015-03-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724603 | SCV000515824 | likely benign | not provided | 2020-11-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000179944 | SCV000597275 | likely benign | not specified | 2016-08-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001083293 | SCV000762466 | likely benign | Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked | 2022-11-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003947532 | SCV004763972 | likely benign | SRPX2-related condition | 2022-03-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000724603 | SCV001928201 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000724603 | SCV001964878 | likely benign | not provided | no assertion criteria provided | clinical testing |